Cargando…
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
BACKGROUND: Telomerase reverse transcriptase (TERT) promoter mutations are associated with increased recurrence and mortality in patients with thyroid carcinoma. Previous studies on TERT promoter mutations were retrospectively conducted on a limited number of patients. METHODS: We prospectively coll...
Autores principales: | Yang, Heera, Park, Hyunju, Ryu, Hyun Jin, Heo, Jung, Kim, Jung-Sun, Oh, Young Lyun, Choe, Jun-Ho, Kim, Jung Han, Kim, Jee Soo, Jang, Hye Won, Kim, Tae Hyuk, Kim, Sun Wook, Chung, Jae Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449103/ https://www.ncbi.nlm.nih.gov/pubmed/35864728 http://dx.doi.org/10.3803/EnM.2022.1477 |
Ejemplares similares
-
LBODP092 Proposal Of Indication For Completion Thyroidectomy In Follicular Thyroid Carcinoma Using TERT Promoter Mutational Status
por: Park, Hyunju, et al.
Publicado: (2022) -
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
por: Kim, Sue Youn, et al.
Publicado: (2022) -
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
por: Park, Hyunju, et al.
Publicado: (2022) -
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
por: Heo, Jung, et al.
Publicado: (2023) -
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)